#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Charlie Romano Email
VP, Global Development Operations . Arvinas
How to contact Charlie Romano
Join and see Charlie's contact info for free!Current Roles
Employees:
537Revenue:
$22.6MAbout
Arvinas is a pharmaceutical company focused on developing new small molecules - known as PROTACs (PROteolysis TArgeting Chimeras) - aimed at degrading disease-causing cellular proteins via proteolysis. Based on innovative research conducted at Yale University by Dr. Craig Crews, Founder and Chief Scientific Advisor, the company is translating natural protein degradation approaches into novel drugs for the treatment of cancer and other diseases. The proprietary PROTAC-based drug paradigm induces protein degradation, rather than protein inhibition, using the ubiquitin proteasome system and offers the advantage of potentially targeting undruggable as well as druggable elements of the proteome. This greatly expands the ability to create drugs for many new, previously unapproachable targets. For more information, visit www.arvinas.com.Arvinas Address
395 Winchester Ave.New Haven, CT
United States